Sigma Healthcare Limited (ASX:SIG)
Australia · Delayed Price · Currency is AUD 2.980
-0.010 (-0.33%)
Aug 7, 2026, 4:17 PM AEST
Sigma Healthcare Ratios and Metrics
Market cap in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 34,277 | 34,516 | 2,081 | 890 | 614 | 630 | |
Market Cap Growth | 2.74% | 1558.90% | 133.83% | 44.83% | -2.52% | -4.81% |
Enterprise Value | 36,112 | 35,551 | 3,049 | 1,899 | 2,353 | - |
Last Close Price | 2.98 | 2.96 | 1.26 | 0.80 | 0.54 | 0.54 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 56.05 | 65.13 | 3.85 | 2.92 | 1.59 | - |
Forward PE | 42.15 | 50.68 | - | - | - | - |
PS Ratio | 3.59 | 5.75 | 0.63 | 0.29 | 0.21 | 0.26 |
PB Ratio | 7.01 | 7.41 | 2.90 | 2.34 | 1.77 | 7.07 |
P/TBV Ratio | 32.95 | 42.61 | 2.93 | 2.35 | 1.79 | 7.01 |
P/FCF Ratio | 77.79 | 63.19 | 8.66 | 2.06 | 2.27 | 2.07 |
P/OCF Ratio | 70.31 | 57.64 | 7.62 | 2.00 | 2.16 | 2.00 |
PEG Ratio | 1.96 | 8.34 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
EV/Sales Ratio | 3.78 | 5.92 | 0.93 | 0.61 | 0.79 | - |
EV/EBITDA Ratio | 36.04 | 44.55 | 5.36 | 4.32 | 4.02 | - |
EV/EBIT Ratio | 39.12 | 46.22 | 5.52 | 4.43 | 4.10 | - |
EV/FCF Ratio | 81.95 | 65.08 | 12.69 | 4.39 | 8.67 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Debt / Equity Ratio | 0.41 | 0.44 | 1.83 | 3.10 | 3.22 | 22.00 |
Debt / EBITDA Ratio | 2.06 | 2.51 | 2.23 | 2.25 | 1.57 | - |
Debt / FCF Ratio | 4.55 | 3.79 | 5.47 | 2.73 | 4.12 | 6.43 |
Net Debt / Equity Ratio | 0.38 | 0.42 | 1.45 | 2.56 | 2.91 | 9.40 |
Net Debt / EBITDA Ratio | 1.97 | 2.42 | 1.83 | 2.21 | 1.73 | -13.49 |
Net Debt / FCF Ratio | 4.18 | 3.54 | 4.33 | 2.25 | 3.73 | 2.75 |
Asset Turnover | - | 1.08 | 1.29 | 1.41 | 1.21 | 0.86 |
Inventory Turnover | - | 5.63 | 4.16 | 4.46 | 4.26 | 4.06 |
Quick Ratio | 1.08 | 1.09 | 1.13 | 0.90 | 0.83 | 0.75 |
Current Ratio | 1.67 | 1.71 | 1.79 | 1.54 | 1.50 | 0.97 |
Return on Equity (ROE) | - | 19.54% | 98.42% | 83.22% | 176.49% | -54.44% |
Return on Assets (ROA) | - | 8.62% | 13.56% | 12.24% | 14.52% | -1.55% |
Return on Invested Capital (ROIC) | 9.36% | 13.02% | 33.42% | 22.29% | 35.21% | -4.54% |
Return on Capital Employed (ROCE) | 13.20% | 11.70% | 29.00% | 30.00% | 41.90% | -9.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Earnings Yield | 1.75% | 1.54% | 26.00% | 34.20% | 62.82% | -27.92% |
FCF Yield | 1.29% | 1.58% | 11.55% | 48.60% | 44.16% | 48.39% |
Dividend Yield | 0.43% | 0.44% | - | - | - | - |
Payout Ratio | 81.13% | 91.72% | 40.24% | 86.77% | 69.77% | - |
Buyback Yield / Dilution | -627.02% | -6.70% | -532.62% | - | -0.13% | - |
Total Shareholder Return | -626.58% | -6.26% | -532.62% | - | -0.13% | - |